Development and in vitro/in vivo evaluation of a nanosponge formulation loaded with Boswellia carterii oil extracts for the enhanced anti-inflammatory activity for the management of respiratory allergies
Rattachement africain : Égypte. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Purpose In several nations, it has been known that Boswellia carterii (BC) plants have a long history of usage as an anti-inflammatory medicine. Our current study deals with the study of two different ways of extraction of BC volatile oil and fixed oil as main constituents (Octyl acetate, 46.46% and β-Boswellic acid, 10.21%, respectively), preparation, and evaluation of Nano sponges loaded with either dexamethasone (DEX) or B. carterii volatile/fixed oil mixture. Methods Nano sponges were created utilizing an ultrasound-assisted synthesis method. Using spectrophotometry, the entrapment efficiency (EE%) of drugs in Nano sponges was considered. Several techniques were used to characterize Nano sponges. Results EE% of drugs inside Nano sponges ranged from 99.15 ± 3.50 to 100% ± 4.76%. Particle size of Nano sponges ranged from 59.9 ± 26.3 to 229.2 ± 30.23 nm. Drugs released from Nano sponges bi-phasically according to Korsmeyer–Peppas model. The anti-inflammatory activity of either B. carterii oil mixture or Dexa salt and their Nano formulations (D4 and O1) in the treatment of respiratory allergy were evaluated in rat model mimicking chronic allergic respiratory diseases. Histopathologic examinations and measurement of Intracellular adhesion molecule-1 (ICAM-1), Leukotriene B4 (LTB4) and Interleukin β4 (ILβ4) levels exposed that, the treatment significantly lowered the levels of the inflammatory biomarkers in treated rats and exhibited improved histopathologic profiles when compared to positive control group. Conclusion Boswellia oil and its Nano sponge formulation O1 as well as Dexa salt Nano sponge formulation D4 had promising therapeutic effects on upper and lower respiratory allergic conditions.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Development and in vitro/in vivo evaluation of a nanosponge formulation loaded with Boswellia carterii oil extracts for the enhanced anti-inflammatory activity for the management of respiratory allergies
- Date Crossref
- 08/04/2024
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.